May 26, 2026

Developing vaccines and therapeutics for Ebola

Journalists came to hear from researchers in the UK who are leading efforts to rapidly develop vaccines and therapeutics for Ebola, specifically for the Bundibugyo virus which is responsible for the current outbreak in the Democratic Republic of the Congo and Uganda.

CEPI were also on the call to discuss the work they’re doing on Ebola and the current outbreak to support the rapid development of effective vaccines.

Speakers included:

Prof Teresa Lambe OBE FMedSci Calleva Head of Vaccine Immunology, Oxford Vaccine Group, Pandemic Sciences Institute, University of Oxford

Dr Amanda Rojek Associate Professor of Health Emergencies, Pandemic Sciences Institute, University of Oxford

Prof Christophe Fraser Moh Family Foundation Professor of Infectious Disease Epidemiology, Nuffield Department of Medicine, University of Oxford

Prof Sir Andrew Pollard FRCPCH FMedSci FRS, Ashall Professor of Infection and Immunity, Pandemic Sciences Institute, and Director of the Oxford Vaccine Group, University of Oxford

Prof Sir Peter Horby, Director of the Pandemic Sciences Institute and Moh Family Foundation Professor of Emerging Infections and Global Health, University of Oxford

Dr Richard Hatchett, CEO of CEPI